25.06.2014 • News

Make Chemistry More Attractive

Dr. Thomas Geelhaar, R&D director of Merck KGaA, Darmstadt, Germany, became President of the Gesellschaft Deutscher Chemiker (GDCh; German Chemical Society) in January 2014 for a two-year term. Besides improving cooperation between industry and academia, Geelhaar has a strong focus on working towards better acceptance of chemistry in society through increased scientific communication.

Dr. Vera Koester talked with him for CHEManager International's sister publication ChemViews magazine about his plans. Read the full Interview.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Interview

The UK Chemical Supply Chain

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Top-Feature

Predictive Simulation in Pharma Production

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Aenova Holding GmbH

Aseptic processing by design: The flexible and efficient use of RABS and Isolators

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

most read

News • Chemistry

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

News • Strategy

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

News • Chemistry

Dow to Shut Down Three Upstream European Assets

Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.